US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novogen

3.17

0.0000

Volume:- -

Turnover:- -

Market Cap:15.32M

PE:-5.76

High:3.17

Open:3.17

Low:3.17

Close:3.17

52wk High:7.60

52wk Low:1.63

Shares:4.83M

Float Shares:4.83M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5500

ROE:--

ROA:--

PB:0.68

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Novogen

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.novogen.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Novogen Limited engages in the pharmaceutical research and development business in Australia. The company primarily has two drug technology platforms, which include superbenzopyran (SBPs) and anti-tropomyosin (ATMs). Its SBP technology platform offers Cantrixil, an intra-cavity anti-cancer agent for the treatment of ovarian cancer, malignant ascites, and malignant pleural effusion; and Trilexium for the treatment of brain cancers, neuroblastoma, and melanoma. Its ATM technology platform provides Anisina that destructs cancer cells cytoskeleton. The company is also developing various programs in the areas of regenerative medicine, facioscapulohumeral muscular dystrophy, and lysosomal storage disorder. Novogen Limited was founded in 1994 and is based in Hornsby, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NVGN/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVGN\",,,,,undefined,":{"symbol":"NVGN","market":"US","secType":"STK","nameCN":"Novogen","latestPrice":3.17,"timestamp":1511384400000,"preClose":3.17,"halted":4,"volume":0,"delay":0,"floatShares":4832880,"shares":4832880,"eps":-0.55,"marketStatus":"Delisted","change":0,"latestTime":"09-09 09:42:37 EDT","open":3.17,"high":3.17,"low":3.17,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.55,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1757448000000},"marketStatusCode":2,"adr":1,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.17,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVGN\",,,,,undefined,":{"symbol":"NVGN","floatShares":4832880,"roa":"--","roe":"--","lyrEps":0,"shares":4832880,"dividePrice":0,"high":3.17,"amplitude":0,"preClose":3.17,"low":3.17,"week52Low":1.63,"pbRate":"0.68","week52High":7.6,"institutionHeld":0.0055,"latestPrice":3.17,"eps":-0.55,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.55,"open":3.17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVGN\",params:#limit:5,,,undefined,":[{"date":"2017-11-24","symbol":"NVGN","newSymbol":"KZIA","type":"symbolChange","dateTimestamp":1511499600000},{"date":"2017-07-14","symbol":"NVGN","type":"split","dateTimestamp":1500004800000,"forFactor":4,"toFactor":1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVGN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.novogen.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0059},{"period":"1month","weight":0.0183},{"period":"3month","weight":0.0759},{"period":"6month","weight":0.161},{"period":"1year","weight":0.2007},{"period":"ytd","weight":0.1071}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Novogen Limited engages in the pharmaceutical research and development business in Australia. The company primarily has two drug technology platforms, which include superbenzopyran (SBPs) and anti-tropomyosin (ATMs). Its SBP technology platform offers Cantrixil, an intra-cavity anti-cancer agent for the treatment of ovarian cancer, malignant ascites, and malignant pleural effusion; and Trilexium for the treatment of brain cancers, neuroblastoma, and melanoma. Its ATM technology platform provides Anisina that destructs cancer cells cytoskeleton. The company is also developing various programs in the areas of regenerative medicine, facioscapulohumeral muscular dystrophy, and lysosomal storage disorder. Novogen Limited was founded in 1994 and is based in Hornsby, Australia.","exchange":"NASDAQ","name":"Novogen","nameEN":"Novogen"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NVGN\",market:\"US\",,,undefined,":null}}